CD44 and breast cancer: The rationale of this study is based on the following observations: i) substantial evidence from the literature indicate that CD146 can suppress BC growth and invasion [2, 22, 23]; and ii) Our gene expression profiling data revealed a six-fold down-regulation of CD146 upon HA-mediated activation of CD44 (data not shown).